Cardiovascular outcome trials on oral antidiabetic drugs
Please note that for mobiles we stream the presentation slides and audio of the speaker.
Professor John Wilding describes the recent studies on oral antidiabetic drugs. Professor Wilding discusses emerging data, results of recent trials, and one particularly beneficial drug - SGL T2i.
This lecture was filmed at the RSM in London for the event 'Preventing premature mortality in diabetes' on the 24th of January 2018.